NVNO Market Analysis
Overview
Price chart · mood · technical indicatorsFundamentals
Updated daily after market closeValuation
- Forward P/E
- —
- PEG ratio
- —
- P/B
- 0.25
- P/S (TTM)
- 216.91
- EV/EBITDA
- -0.87
Profitability & growth
- ROE (TTM)
- -56.2%
- Operating margin
- 0.0%
- Revenue growth YoY
- 0.0%
- Dividend yield
- —
- Beta
- 1.08
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
News & Sentiment
50 articles · sorted by dateVia 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
About enVVeno Medical Corp
Company profileenVVeno Medical Corp is an innovative medical device company dedicated to transforming vascular access solutions for dialysis patients through its proprietary biocompatible technology. By addressing critical unmet needs in the dialysis sector, enVVeno enhances the safety and efficacy of vascular procedures, allowing it to capitalize on the growing vascular interventions market. The company's commitment to advanced engineering, coupled with stringent regulatory compliance, aligns it with the evolving healthcare landscape and reinforces its mission to improve patient outcomes in a vital area of…
Classification
- Sector
- Healthcare
- Industry
- Medical Devices
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 70 DOPPLER, IRVINE, CA
- Fiscal year end
- December
- Latest quarter
- Dec 31, 2025
Educational content · Not investment advice or recommendations
We're educators, not advisors. Your decisions are your own. Disclaimer
I'm your AI thinking companion for the markets — I can help you explore and learn, but I'm not a financial advisor. Everything here is educational. Disclaimer